No-Shows Increase If MRI Wait Time Longer than 7 Days
Longer wait times increase no-show rates for MRIs.
Longer wait times for advanced imaging appointments increase the chance of missed appointments, according to a study published in The Journal of the American College of Radiology.
Researchers from Massachusetts General Hospital and Harvard Medical School in Boston, performed a retrospective study to investigate the impact of wait days (WDs) on missed outpatient MRI appointments across different demographic and socioeconomic factors.
The researchers obtained scheduling and demographic data on 42,727 adult patients. Imaging missed appointments were defined as missed scheduled imaging encounters and WDs were defined as the number of days from study order to appointment.
The results showed that mean WDs were 7.95 days. There was an increased odds ratio for missed appointments for patients with WDs of between 7 and 21 days. Increased WDs were also found among patients who were African American or Hispanic, as well as for patients with noncommercial insurance, and whose imaging was to be performed at the main hospital campus.
The researchers concluded that longer wait times significantly increased the likelihood of missed appointments, particularly among underrepresented minorities and those who are socioeconomically disadvantaged.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
